Real world, Non-interventional, Observational Study of acotiamide hydrochloride hydrate in functional dyspepsia

Dr Reddys Laboratories Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Patients clinically diagnosed with functional dyspepsia where physician has taken decision to prescribe acotiamide hydrochloride hydrate.
•2.Patients with Functional Dyspepsia as defined by Rome III criteria
•Diagnostic criteria Must include: One or more of the following:
•a. Bothersome postprandial fullness
•b. Early satiation
•c. Epigastric pain
•d. Epigastric burning
•and No evidence of structural disease (including at upper endoscopy) that is likely to explain the symptoms
•Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis

•1.Patients with a known or suspected hypersensitivity to acotiamide or to any ingredients of the formulation
•2.Patients on cholinergic drugs as part of therapy
•3.Patients on prokinetics as a part of therapy
•4.Structural lesion evident in endoscopy
•5.Coexisting Irritable bowel syndrome
•6.Heartburn in past 12 weeks
•7.Pregnant and lactating women

发起方